Alexion
Alexion Acquires Voyager’s Preclinical Capsid for Rare Neurological Disease After $1B Pfizer Transfer
Anika Sharma
Pfizer has transferred an AAV capsid designed for a rare neurological disease target to AstraZeneca’s rare disease subsidiary, Alexion, as ...
Alexion settles Soliris sales practices lawsuit for $125 million
Anika Sharma
After nearly seven years since the departure of Alexion’s CEO and CFO amidst an investigation into improper sales practices, the ...
